Should You Change Your Transfer Protocol After Recurrent Implantation Failure?
After repeated failed transfers, changing the protocol is tempting — but, as with day-3 arrest, it should be a decision tied to a finding, not a reflex. The right move depends on which domain your work-up implicates: a cavity problem needs surgery, not a new drug; an unexplained case needs caution against unproven “boosters.” This framework matches the evidence-based options to your specific pattern. General education, not individual medical advice.
A decision framework
Step 1 — Which domain did your review implicate?
– Structural (cavity/hydrosalpinx) → surgical route.
– Embryo (aneuploidy) → screening or donor gametes.
– Thin lining → endometrial optimization.
– Confirmed thrombophilia/APS → specific medication.
– Nothing found → avoid unproven add-ons; plan a careful retry.
Step 2 — Match the option to the pattern.
| If the pattern is… | Option with the best rationale | Evidence note |
|---|---|---|
| Cavity abnormality (polyp/fibroid/septum) | Hysteroscopy + resection | Strong |
| Hydrosalpinx | Salpingectomy before transfer | Strong |
| Recurrent aneuploidy / advanced age | PGT-A; discuss donor oocytes | Evidence-based for selection |
| Thin or poor lining | Estrogen, protocol adjustment | Moderate |
| Confirmed antiphospholipid syndrome | Aspirin / heparin | Evidence-based for APS |
| Unexplained | Avoid unproven immunotherapy; ERA only in defined plan | Limited; caution |
What the evidence does — and doesn’t — support
- Strongest: treating structural lesions, salpingectomy for hydrosalpinx, PGT-A for selection, anticoagulation for confirmed APS.
- Weaker / variable: endometrial scratch (trials show no benefit), routine immunotherapy, assisted hatching.
- Not supported: adding expensive “immune” treatments when no indication exists.
What a protocol change can and cannot do
- Can: fix a treatable structural or chromosomal issue and improve the odds per transfer.
- Cannot: guarantee implantation, or compensate for an untreatable uterine factor (where donor embryos or a gestational carrier may be the honest discussion).
Related reading
- The cause framework: What Is Recurrent Implantation Failure?
- Build the review first: What to Review Before Your Next Transfer
- Avoid over-testing: RIF and Unexplained: What the Evidence Can—and Cannot—Tell You
- Male side: Could Sperm Quality or DNA Fragmentation Cause RIF?
Your next step
Not sure a change is justified? The IVF Case Clarity Assessment lines up your RIF pattern with the options worth raising with your specialist.
Medical disclaimer
General education only; not individual medical advice. Protocol changes, surgery, PGT-A, and medications are decisions made with your reproductive specialist.
References
- Practice Committee of ASRM. Preimplantation genetic testing: a committee opinion. Fertil Steril. 2024.
- Practice Committee of ASRM. Salpingectomy for hydrosalpinx prior to IVF. Fertil Steril. 2015/2016.
- Practice Committee of ASRM. Role of immunotherapy in in vitro fertilization: a committee opinion. Fertil Steril. 2018 (updated).
- Coughlan C, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online. 2014.